PT2298766E - Formulação farmacêutica compreendendo derivados de piridina substituída - Google Patents
Formulação farmacêutica compreendendo derivados de piridina substituída Download PDFInfo
- Publication number
- PT2298766E PT2298766E PT101820728T PT10182072T PT2298766E PT 2298766 E PT2298766 E PT 2298766E PT 101820728 T PT101820728 T PT 101820728T PT 10182072 T PT10182072 T PT 10182072T PT 2298766 E PT2298766 E PT 2298766E
- Authority
- PT
- Portugal
- Prior art keywords
- pyridin
- morpholin
- dimethyl
- acetamide
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65842805P | 2005-03-03 | 2005-03-03 | |
| DKPA200500321 | 2005-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2298766E true PT2298766E (pt) | 2013-11-07 |
Family
ID=37908541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT101820728T PT2298766E (pt) | 2005-03-03 | 2006-03-02 | Formulação farmacêutica compreendendo derivados de piridina substituída |
Country Status (14)
| Country | Link |
|---|---|
| KR (2) | KR20130088905A (xx) |
| CN (3) | CN102276523B (xx) |
| AR (1) | AR052931A1 (xx) |
| BR (1) | BRPI0608122A2 (xx) |
| DK (1) | DK2298766T3 (xx) |
| EA (1) | EA016244B1 (xx) |
| ES (1) | ES2433593T3 (xx) |
| HK (1) | HK1164868A1 (xx) |
| IL (1) | IL185113A (xx) |
| NZ (1) | NZ556613A (xx) |
| PT (1) | PT2298766E (xx) |
| SI (1) | SI2298766T1 (xx) |
| UA (1) | UA92340C2 (xx) |
| ZA (1) | ZA200705987B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114409593B (zh) * | 2022-01-20 | 2024-02-23 | 上海泾维化工科技有限公司 | 一种2-氨基-5-甲基吡啶的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001010380A2 (en) * | 1999-08-04 | 2001-02-15 | Icagen, Inc. | Benzanilides as potassium channel openers |
| DE60115656T2 (de) * | 2000-06-29 | 2006-06-14 | Neurosearch As | Verwendung von 3-substituierten oxidinolderivaten als kcnq kaliumkanalmodulatoren |
| JP2005508833A (ja) * | 2001-02-20 | 2005-04-07 | ブリストル−マイヤーズ スクイブ カンパニー | Ｋｃｎｑカリウムチャネル・モジュレーターとしての２，４−ジ置換ピリミジン−５−カルボキサミド誘導体 |
| CA2519582A1 (en) * | 2003-03-21 | 2004-09-30 | H. Lundbeck A/S | Substituted p-diaminobenzene derivatives |
| TWI349666B (en) * | 2004-03-12 | 2011-10-01 | Lundbeck & Co As H | Substituted morpholine and thiomorpholine derivatives |
-
2006
- 2006-02-03 UA UAA200710648A patent/UA92340C2/ru unknown
- 2006-03-02 ZA ZA200705987A patent/ZA200705987B/xx unknown
- 2006-03-02 SI SI200631682T patent/SI2298766T1/sl unknown
- 2006-03-02 PT PT101820728T patent/PT2298766E/pt unknown
- 2006-03-02 AR ARP060100790A patent/AR052931A1/es unknown
- 2006-03-02 CN CN201110168073.8A patent/CN102276523B/zh not_active Expired - Fee Related
- 2006-03-02 KR KR1020137019572A patent/KR20130088905A/ko not_active Application Discontinuation
- 2006-03-02 ES ES10182072T patent/ES2433593T3/es active Active
- 2006-03-02 CN CN2011103097414A patent/CN102516165A/zh active Pending
- 2006-03-02 BR BRPI0608122-3A patent/BRPI0608122A2/pt not_active IP Right Cessation
- 2006-03-02 NZ NZ556613A patent/NZ556613A/en not_active IP Right Cessation
- 2006-03-02 KR KR1020077019782A patent/KR20070108884A/ko not_active Application Discontinuation
- 2006-03-02 CN CNA2006800068313A patent/CN101133053A/zh active Pending
- 2006-03-02 DK DK10182072.8T patent/DK2298766T3/da active
- 2006-03-02 EA EA200701877A patent/EA016244B1/ru not_active IP Right Cessation
-
2007
- 2007-08-07 IL IL185113A patent/IL185113A/en not_active IP Right Cessation
-
2012
- 2012-06-07 HK HK12105602.5A patent/HK1164868A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| UA92340C2 (xx) | 2010-10-25 |
| CN101133053A (zh) | 2008-02-27 |
| BRPI0608122A2 (pt) | 2010-11-09 |
| AR052931A1 (es) | 2007-04-11 |
| EA200701877A1 (ru) | 2008-02-28 |
| EA016244B1 (ru) | 2012-03-30 |
| KR20130088905A (ko) | 2013-08-08 |
| IL185113A0 (en) | 2007-12-03 |
| IL185113A (en) | 2013-10-31 |
| NZ556613A (en) | 2010-11-26 |
| SI2298766T1 (sl) | 2014-05-30 |
| ZA200705987B (en) | 2009-05-27 |
| DK2298766T3 (da) | 2013-11-11 |
| CN102276523B (zh) | 2014-12-10 |
| CN102276523A (zh) | 2011-12-14 |
| KR20070108884A (ko) | 2007-11-13 |
| CN102516165A (zh) | 2012-06-27 |
| ES2433593T3 (es) | 2013-12-11 |
| HK1164868A1 (en) | 2012-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2298766B1 (en) | Pharmaceutical formulations comrpising a substituted pyridine derivative | |
| ES2306087T3 (es) | Derivados de morfolina y tiomorfolina sustituidos. | |
| US7355054B2 (en) | Indole derivatives | |
| US7683058B2 (en) | Substituted pyrimidine derivatives | |
| BRPI0615631A2 (pt) | composto, composição farmacêutica, e, uso de uma composição farmacêutica | |
| HU227163B1 (en) | Dervatives of tryptamine and analogous compounds and pharmaceutical compositions containing them | |
| PT2298766E (pt) | Formulação farmacêutica compreendendo derivados de piridina substituída | |
| ZA200507186B (en) | Substituted indoline and indole derivatives | |
| HRP20080507A2 (hr) | Supstituirani derivati morfolina i tiomorfolina |